Molnupiravir: UK becomes first country to approve oral Covid pill; All you need to know about Covid drug

Merck's Molnupiravir, the COVID-19 antiviral pill has been designed to introduce the errors into the genetic code of the virus that causes COVID-19. The oral antiviral treatment will be branded as ‘Lagevrio’ in Britain.



Check These Popular Posts